A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Part of paid clinical trials in Santa Monica, California.

Sponsor
UCB Biopharma SRL
Study ID
NCT06888193
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Bimekizumab — DRUG
    Bimekizumab under the care of their treating physician.

Study Details

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Key Dates

Start date
Nov 5, 2025
Status verified
Apr 2026
Primary completion
May 3, 2027
Completion
May 3, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Bimekizumab
    Breastfeeding mothers who are already receiving commercial bimekizumab per locally approved prescribing information and in consultation and agreement with their treating physicians will participate in this study. Study participants will continue receiving commercially available bimekizumab under the care of their treating physician.

Primary Outcome Measure

Concentration of bimekizumab in the breast milk on Day 1 [ Time Frame: Day 1 ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Up0122 105Santa MonicaCalifornia90404-
Up0122 103South MiamiFlorida33155-
Up0122 102DurhamNorth Carolina27710-
Up0122 101MilwaukeeWisconsin53226-

Find similar trials in Santa Monica, CA

By condition
Hidradenitis suppurativaPsoriatic arthritis
By specialty
DermatologyRheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Up0122 105· Santa Monica, CAUp0122 103· South Miami, FLUp0122 102· Durham, NCUp0122 101· Milwaukee, WI

Related Studies